FDA vs EMA Guidelines for Bioequivalence Submissions: Key Differences and Harmonization Challenges
FDA vs EMA Guidelines for Bioequivalence Submissions: Key Differences and Harmonization Challenges Comparing FDA and EMA Guidelines for Bioequivalence Submissions Introduction: Why FDA vs EMA BE Guidelines Matter In the global pharmaceutical market, submitting bioequivalence (BE) study results to both the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) is increasingly…